Magnetic
nanocapsules were synthesized for controlled drug release,
magnetically assisted delivery, and MRI imaging. These magnetic nanocapsules,
consisting of a stable iron nanocore and a mesoporous silica shell,
were synthesized by controlled encapsulation of ellipsoidal hematite
in silica, partial etching of the hematite core in acid, and reduction
of the core by hydrogen. The iron core provided a high saturation
magnetization and was stable against oxidation for at least 6 months
in air and 1 month in aqueous solution. The hollow space between the
iron core and mesoporous silica shell was used to load anticancer
drug and a T1-weighted MRI contrast agent (Gd-DTPA). These
multifunctional monodispersed magnetic “nanoeyes” were
coated by multiple polyelectrolyte layers of biocompatible poly-l-lysine and sodium alginate to control the drug release as
a function of pH. We studied pH-controlled release, magnetic hysteresis
curves, and T1/T2 MRI contrast of the magnetic
nanoeyes. They also served as MRI contrast agents with relaxivities
of 8.6 mM–1 s–1 (r1) and 285 mM–1 s–1 (r2).